Roche Diagnostics Operations, Inc.
FDA Regulatory Profile
Roche Diagnostics Operations, Inc. has 127 FDA recalls, 9 inspections, 7 510(k) clearances and 0 compliance actions on record.
- Latest recall
- Z-1476-2026 · Class II · Jan 20, 2026
- Latest inspection
- Dec 7, 2022 · NAI
- Latest 510(k)
- Jan 24, 2025
Newer recall under related name Foundation Medicine: Jun 10, 2026, Z-2951-2026.
Reviewing Roche Diagnostics Operations, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Check this supplier
Or check Roche Diagnostics Operations, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Get a free API key
Summary
Record counts and when each FDA source was last refreshed
| Records | Count | Last refreshed | Source as of | Status |
| Recalls | 127 | Nov 8, 2026 | File dated Nov 3, 2026 | Current |
| 510(k) clearances | 7 | Nov 8, 2026 | File dated Nov 2, 2026 | Current |
| Inspections | 9 | Nov 11, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
Recent Recalls
| Number | Class | Product | Date |
| Z-1476-2026 | Class II | cobas pro integrated solutions with cobas c 503 analytical units: cobas pro sample supply unit… | Jan 20, 2026 |
| Z-1009-2026 | Class II | The Elecsys Anti-TSHR immunoassay is a three-step competitive immunoassay with streptavidin-coated… | Nov 21, 2025 |
| Z-0489-2025 | Class II | cobas HCYS, Homocysteine Enzymatic Assay, Material Number REF 06542921190, for use on cobas c… | Oct 17, 2024 |
| Z-3187-2024 | Class II | Creatine Kinase (CK) used on cobas c 311/501/502 and COBAS INTEGRA 400 plus-In vitro test for the… | Aug 15, 2024 |
| Z-0352-2024 | Class II | Tina-quant D-Dimer Test System, Fibrinogen/Fibrin Degradation Products Assay, Material Numbers… | Oct 3, 2023 |
| Z-0952-2023 | Class II | cobas infinity central lab, Material Number 07154003001 | Dec 12, 2022 |
| Z-1515-2022 | Class II | cobas e801 Immunoassay Analyzer | Jul 14, 2022 |
| Z-0266-2022 | Class II | Cobas u 601 urinalysis test system, Catalog number 06334601001 The cobas U 601 urinalysis test… | Oct 18, 2021 |
| Z-2444-2021 | Class II | cobas infinity central lab running software version 3.01.03 through 3.02.08, Catalog#: 07154003001 | Jun 24, 2021 |
| Z-1675-2021 | Class II | IRON GEN 2: ROCHE COBAS INTEGRA ANALYZER, REAGENT CASSETTES, Catalog#: 03183696122 - Product Usage… | Apr 26, 2021 |
| Z-1595-2021 | Class II | Elecsys Troponin I STAT Immunoassay: Catalog# 05094798160 - Product Usage: intended to aid in the… | Apr 7, 2021 |
| Z-1596-2021 | Class II | Elecsys Troponin I Immunoassay: Catalog# 05094810160 - Product Usage: intended to aid in the… | Apr 7, 2021 |
| Z-1098-2021 | Class II | 9180 Electrolyte Analyzer - Product Usage: intended to be used for the measurement of sodium… | Jan 6, 2021 |
| Z-0883-2021 | Class II | A calculator/data processing module for clinical use is an electronic device intended to store… | Dec 17, 2020 |
| Z-0754-2021 | Class II | Roche cobas 8000 modular analyzer series (i.e., cobas 8000 ISE module; cobas c 502, 701, and 702… | Dec 8, 2020 |
| Z-0755-2021 | Class II | Roche cobas pro integrated solutions (cobas pro ISE, cobas c 503, and cobas e 801 analytical units)… | Dec 8, 2020 |
| Z-0803-2021 | Class II | CoaguChek XS Prof (Professional) Meters- IVD professional healthcare providers for quantitative… | Dec 2, 2020 |
| Z-0804-2021 | Class II | CoaguChek XS PST Meters- IVD (Patient Self-Testing) measures blood-clotting time for people who are… | Dec 2, 2020 |
| Z-0752-2021 | Class II | cobas pro integrated solutions -cobas c 503, Analyzer, chemistry (photometric discrete), for… | Nov 23, 2020 |
| Z-0634-2021 | Class II | Tina-quant C-Reactive Protein Gen.3, Catalog number 05172373190 - Product Usage: the in vitro… | Nov 6, 2020 |
Recent FDA Inspections
| Date | Site | Product | Classification | FEI |
| Dec 7, 2022 | Indianapolis, IN | Devices | No Action Indicated (NAI) | 1823260 |
| Jun 27, 2019 | Indianapolis, IN | Devices | Voluntary Action Indicated (VAI) | 1823260 |
| Oct 14, 2016 | Indianapolis, IN | Devices | No Action Indicated (NAI) | 1823260 |
| Aug 15, 2016 | Indianapolis, IN | Devices | Voluntary Action Indicated (VAI) | 1823260 |
| Jul 7, 2015 | Indianapolis, IN | Devices | No Action Indicated (NAI) | 1823260 |
| Oct 17, 2012 | Indianapolis, IN | Devices | No Action Indicated (NAI) | 1823260 |
| Nov 23, 2011 | Indianapolis, IN | Devices | Voluntary Action Indicated (VAI) | 1823260 |
| Jan 21, 2011 | Indianapolis, IN | Devices | No Action Indicated (NAI) | 1823260 |
| Jun 3, 2010 | Indianapolis, IN | Devices | No Action Indicated (NAI) | 1823260 |
NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.
FDA-Inspected Facilities
| Facility | Location | Inspections | Latest |
| FEI 1823260 | Indianapolis, IN | 9 | Dec 7, 2022 |
Recent 510(k) Clearances
| K-Number | Device | Date |
| K241220 | Tina-quant Lipoprotein(a) Gen.2 Molarity | Jan 24, 2025 |
| K233454 | ONLINE TDM Methotrexate | Feb 20, 2024 |
| K163633 | cobas HbA1c Test, cobas b 101 system | Jul 28, 2017 |
| K131366 | ACCU-CHEK AVIVA EXPERT BLOOD GLUCOSE MONITORING SYSTEM | Oct 11, 2013 |
| K131029 | ACCU-CHEK AVIVA PLUS TEST STRIP | Aug 9, 2013 |
| K121610 | COBAS C 501 TINA-QUANT HBA1CDX GEN.3 ASSAY | Aug 8, 2013 |
| K113072 | TINA-QUANT ALBUMIN GEN.2 | May 14, 2012 |